BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4656588)

  • 1. [Differentiation of phenobarbital and methylphenobarbital by Pesez's reaction].
    Bouché R
    Ann Pharm Fr; 1972 Oct; 30(10):701-5. PubMed ID: 4656588
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of phenobarbital, phenytoin and methylphenobarbital in tablet formulations by HPLC.
    Vio L; Mamolo MG; Furlan G
    Farmaco Prat; 1988 May; 43(5):157-64. PubMed ID: 3181414
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous spectrophotometric determination of phenobarbital, phenytoin and methylphenobarbital in pharmaceutical preparations by using partial least-squares and principal component regression multivariate calibration.
    Boeris ; Luco JM; Olsina RA
    J Pharm Biomed Anal; 2000 Dec; 24(2):259-71. PubMed ID: 11130205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved UV-spectrophotometric method for routine barbiturate monitoring.
    Jeremić V; Nikolić R
    J Clin Chem Clin Biochem; 1976 Oct; 14(10):479-83. PubMed ID: 993734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the physicochemical properties of the binary complexes FeL2(OH)1,5H2O and FeP2(OH). Measurement of the pharmacological properties for the compound FeL2(OH)1,5H2O.
    Domínguez A; Jiménez H
    Pharm Acta Helv; 1987; 62(10-11):317-20. PubMed ID: 3438318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of phenobarbital in suppositories in a non-aqueous medium].
    Résibois B; Hodé C
    J Pharm Belg; 1970; 25(5):343-56. PubMed ID: 5494307
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats.
    Craig CR; Shideman FE
    J Pharmacol Exp Ther; 1971 Jan; 176(1):35-41. PubMed ID: 5569636
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectrophotometric determination of phenobarbitone, methylphenobarbitone and phenytoin in tablets.
    Wahbi AM; Bararay M
    Analyst; 1980 Sep; 105(1254):855-60. PubMed ID: 7447028
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of methylphenobarbital in man.
    Hooper WD; Kunze HE; Eadie MJ
    Ther Drug Monit; 1981; 3(1):39-44. PubMed ID: 7233487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intoxication due to replacement of the precursor methylphenobarbital by phenobarbital].
    Heeringa-Karreman M; van Munster ET
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):977-9. PubMed ID: 17225740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrophotometric and polarographic analysis for phenobarbital, N-methylphenobarbital and N-methoxymethylphenobarbital in a mixture.
    Romer M; Donaruma LG; Zuman P
    Anal Chim Acta; 1977 Feb; 88(2):261-73. PubMed ID: 835829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Necessary controls for the chemical reagents used in clinical chemistry].
    Rocchi B
    Ann Ist Super Sanita; 1971; 7(2):323-8. PubMed ID: 5154651
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous assay of methylphenobarbital and phenobarbital in plasma using gas chromatography--mass spectrometry with selected ion monitoring.
    Hooper WD; Kunze HE; Eadie MJ
    J Chromatogr; 1981 May; 223(2):426-31. PubMed ID: 7251798
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and structure determination of a new thiamine-formaldehyde compound.
    Fumagalli A; Checchi G; Pasotti P
    Farmaco Sci; 1971 Aug; 26(8):736-40. PubMed ID: 5092674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative determination and optimal conditions for the extraction of phenobarbital].
    Popova VI
    Farm Zh; 1967; 22(1):36-9. PubMed ID: 5600208
    [No Abstract]   [Full Text] [Related]  

  • 16. [STructure determination by NMR-spectroscopy I].
    Kessler H
    Arch Pharm Ber Dtsch Pharm Ges; 1969 Aug; 302(8):177-96. PubMed ID: 5267021
    [No Abstract]   [Full Text] [Related]  

  • 17. [Place determination of acetyl-groups in acetates of digoxin by nuclear magnetic resonance spectroscopy].
    Maerten G; Haberland G
    Arzneimittelforschung; 1970 Mar; 20(3):347-51. PubMed ID: 5467507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of weak-acid drugs using a volumetric solution of sodium hydridoborate].
    Bachratá M; Subert J; Bezáková Z; Knazko L
    Cesk Farm; 1976 May; 25(3-4):98-101. PubMed ID: 988844
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of a cupric derivative of triazene n-oxide for volumetric analysis of phenobarbital].
    Zosimo-Landolfo G; Tronchet JM; Eder H; Balkadjian M
    Pharm Acta Helv; 1990; 65(7):194-5. PubMed ID: 2388924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dimers from o-nitrobenzylidene acetoacetic esters].
    Görlitzer K; Fabian J; Trittmacher J
    Pharmazie; 2005 Aug; 60(8):571-3. PubMed ID: 16124397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.